New hope for back pain: drug trial targets ankylosing spondylitis
Disease control
Recruiting now
This study tests a new drug called LNK01001 for people with active ankylosing spondylitis, a type of arthritis that causes back pain and stiffness. About 352 adults who haven't gotten enough relief from standard anti-inflammatory drugs will receive either LNK01001 or a placebo fo…
Phase: PHASE3 • Sponsor: Lynk Pharmaceuticals Co., Ltd • Aim: Disease control
Last updated May 11, 2026 20:51 UTC